Skip to main content
Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
601.00
-11.00 (-1.80%)
Apr 28, 2026, 4:43 PM GMT

Oxford Biomedica Revenue

In the year 2025, Oxford Biomedica had annual revenue of 168.74M GBP with 31.01% growth. Oxford Biomedica had revenue of 95.52M in the half year ending December 31, 2025, with 105.51% growth.

Revenue
168.74M
Revenue Growth
+31.01%
P/S Ratio
4.31
Revenue / Employee
172.71K
Employees
977
Market Cap
726.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025168.74M39.94M31.01%
Dec 31, 2024128.80M39.26M43.84%
Dec 31, 202389.54M-50.45M-36.04%
Dec 31, 2022139.99M-2.81M-1.97%
Dec 31, 2021142.80M55.07M62.77%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oxford Nanopore Technologies 223.90M
Genus 672.00M
Avacta Group 113.00K
PureTech Health 4.66M
Scancell Holdings 4.71M
Bioventix 12.54M
Faron Pharmaceuticals Oy 1.14M
4basebio 1.78M
Revenue Rankings

Oxford Biomedica News

More News